Document Detail

Long-term incidence of death due to thromboembolic disease among patients with unprovoked pulmonary embolism.
MedLine Citation:
PMID:  19458530     Owner:  NLM     Status:  MEDLINE    
PURPOSE OF REVIEW: To summarize recent studies that have quantified the incidence of death due to late thromboembolic disease among patients initially diagnosed with acute unprovoked pulmonary embolism. These findings will aid clinicians who must weigh the risk versus the benefits of long-term anticoagulant therapy. RECENT FINDINGS: The incidence of death due to fatal acute recurrent pulmonary embolism following 3-6 months of anticoagulant therapy is approximately 0.2-0.4% per year, depending in part on the presence or absence of chronic comorbidity. In addition, up to 1-3% of all patients with pulmonary embolism are diagnosed with chronic thromboembolic pulmonary hypertension within 3 years of the index event. Patients with acute pulmonary embolism who develop acute pulmonary hypertension greater than 50 mmHg that does not resolve in the first few weeks are at highest risk for progression, particularly if the event is recurrent pulmonary embolism. SUMMARY: The incidence of death due to recurrent pulmonary embolism or significantly debilitating or fatal thromboembolic pulmonary hypertension in the first 3 years after anticoagulant treatment is discontinued is approximately 1-3%. In patients in whom the risk of fatal or disabling hemorrhage is lower, the benefits of chronic anticoagulation may outweigh the risks.
Richard H White; Susan Murin
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in pulmonary medicine     Volume:  15     ISSN:  1531-6971     ISO Abbreviation:  Curr Opin Pulm Med     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-07-28     Completed Date:  2009-11-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9503765     Medline TA:  Curr Opin Pulm Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  418-24     Citation Subset:  IM    
Division of General Internal Medicine, University of California, Davis, Sacramento, California 95817, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cause of Death / trends
Death, Sudden, Cardiac / epidemiology,  etiology
Follow-Up Studies
Pulmonary Embolism / complications*,  mortality
Risk Factors
Survival Rate / trends
Thromboembolism / complications,  mortality*
Time Factors
World Health

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Is replacement therapy with nutritional and active forms of vitamin D required in chronic kidney dis...
Next Document:  Fatigue in sarcoidosis: a systematic review.